BioVie is testing a drug candidate called bezisterim for Long COVID and has received funding from the U.S. Department of Defense.
1 report, 1 independent
Updated May 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
BioVie is testing a drug candidate called bezisterim for Long COVID and has received funding from the U.S. Department of Defense.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Biovie
French company founded in 2007, specializing in online sales of organic, raw, and living foods, committed to education on healthy eating.
Nothing else this week.